VivoSim Labs, Inc. (VIVS:NASDAQ) closed at $0.149 on October 23, 2026, down 6.84% on the day. The stock trades 95.6% below its 52-week high of $3.40 and 3.0% above its 52-week low of $0.144. Over the past year, it lost 93.6%. VivoSim Labs, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, VIVS closed higher on 79 days (31%). Its best day was January 30, 2026 (+71.76%) and its worst was July 16, 2026 (-28.24%). The stock moved 10% or more in a single session 26 times. It opened at least 5% above the previous day's high 4 times.
Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.
Find more stocks like VIVS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.